Safety and efficacy of direct acting oral anticoagulants in the treatment of patients with morbid obesity with venous thromboembolism: A meta-analysis. [PDF]
Shi J, Zhang Y, Tang Y, Wang L, Xiao H.
europepmc +1 more source
Assessment of community pharmacists' knowledge on rivaroxaban drug and food interactions in Sudan. [PDF]
Dakah A +5 more
europepmc +1 more source
Efficacy and safety of rivaroxaban versus low-molecular-weight heparin for the prevention of symptomatic in-hospital venous thrombosis following primary total hip and knee arthroplasty: a large-sample, multicenter, retrospective study. [PDF]
Liao Y +5 more
europepmc +1 more source
Comparative efficacy and safety of aspirin, low-molecular-weight heparin, and rivaroxaban for deep venous thrombosis prophylaxis after hip arthroplasty for femoral neck fracture: a single-center randomized controlled trial. [PDF]
Miao S +6 more
europepmc +1 more source
Correction: Navigating drug-drug interactions with apalutamide. [PDF]
Siddiqui BA +4 more
europepmc +1 more source
Quality of life and functional recovery after venous stent placement for postthrombotic syndrome: insights from the ARIVA multinational randomized trial. [PDF]
Barco S +9 more
europepmc +1 more source
Updates in Hospital Medicine: Anticoagulation. [PDF]
Tsomides AM, Zemrak WR, Gordon LB.
europepmc +1 more source
Rivaroxaban plus antiplatelet therapy for coronary artery ectasia: 36-month outcomes and risk prediction from a retrospective cohort study. [PDF]
Feng M +8 more
europepmc +1 more source
Optimal Antithrombotic Therapy for Peripheral Artery Disease: A Systematic Review and Network Meta-Analysis. [PDF]
Hiruma Y +9 more
europepmc +1 more source
Rivaroxaban versus low-molecular-weight heparin and fondaparinux for preventing deep vein thrombosis after total knee arthroplasty in high-altitude residents: a randomized controlled trial. [PDF]
Ren L +6 more
europepmc +1 more source

